Pharvaris N.V. (PHVS)
$31.10-0.06%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.2B
- Beta
- -2.32
- P/E (TTM)
- -10.24
- Short % float
- 6.05%
- Days to cover
- 2.8
- SI change
- +12.5%
- 1W
- -0.29%
- 1M
- -17.09%
- vs SPY 1W
- -1.45%
- vs SPY 1M
- -20.08%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on PHVS?
- LOPJLB’s latest quantitative signal on Pharvaris N.V. (PHVS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PHVS in?
- Pharvaris N.V. (PHVS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Pharvaris N.V. (PHVS) do?
- Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and…